Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes Jiang-Wei ZhangYong LiuLing Yang Pharmacokinetics and Disposition 28 April 2006 Pages: 497 - 502
Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone Tiina JaakkolaJanne T. BackmanPertti J. Neuvonen Pharmacokinetics and Disposition 03 May 2006 Pages: 503 - 509
Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration Petra A. ThürmannJacek SzymanskiC. Sonnenburg Pharmacokinetics and Disposition 05 May 2006 Pages: 511 - 512
Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers Rasmus Steen PedersenPer DamkierKim Brøsen Pharmacokinetics and Disposition 09 June 2006 Pages: 513 - 521
Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients Eric DaillyOlivier TributPascale Jolliet Pharmacokinetics and Disposition 09 June 2006 Pages: 523 - 526
Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver Wael S. Al-JahdariKoujirou YamamotoRyuya Horiuchi Pharmacokinetics and Disposition 09 June 2006 Pages: 527 - 533
Influence of carvedilol on serum digoxin levels in heart failure: is there any gender difference? Nezihi BarisSule KalkanHulya Guven Pharmacokinetics and Disposition 10 June 2006 Pages: 535 - 538
Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo Agneta WennerholmAnna NordmarkLars L. Gustafsson Pharmacokinetics and Disposition 17 June 2006 Pages: 539 - 546
Associations between socio-economic factors and the use of prescription medication during pregnancy Charlotte OlesenNana ThraneJørn Olsen Pharmacoepidemiology and Prescription 04 May 2006 Pages: 547 - 553
The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very old Inga KlarinJohan FastbomAnders Wimo Pharmacoepidemiology and Prescription 10 May 2006 Pages: 555 - 562
Primary care physicians’ behaviors towards risk of iatrogenesis in elderly patients Bruno FantinoNicolas VoirinEric Van Ganse Pharmacoepidemiology and Prescription 13 May 2006 Pages: 563 - 570
Favorable effect on postgraduate clinical practice of a drug-interaction exercise for undergraduate students Shuichi TsuruokaAtsuhiro KawaguchiAkio Fujimura Pharmacoepidemiology and Prescription 23 May 2006 Pages: 571 - 576
Narrow and wide prescribers among general practitioners Allan BuusmanJakob KragstrupMorten Andersen Pharmacoepidemiology and Prescription 17 June 2006 Pages: 577 - 583
Absence of CYP2B6 promoter −82T>C mutation in Chinese as an additional factor for slow metabolism of drugs commonly used in infections Ming-liang HeCK LinShui-shan Lee Letter to the Editors 13 June 2006 Pages: 585 - 586
Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam Sándor DrabantMária TóthImre Klebovich Letter to the Editors 22 June 2006 Pages: 587 - 588